Close Menu

NEW YORK – BiomX of Israel said on Wednesday that it is collaborating with Boehringer Ingelheim to discover biomarkers associated with patient phenotypes in inflammatory bowel disease.

Under the agreement, BiomX will generate metagenomic data for gut microbiome samples from IBD patients using its XMarker biomarker discovery platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.